Autolus Therapeutics logo

Autolus Therapeutics

AUTL | NASDAQ
Chart Builder DCF Calculator
$1.94
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.97
+$0.03 (+1.55%)
Pre-market: Sep 22, 2026, 4:00 AM ET

Market Data

Market Cap
$516.32M
Enterprise Value
$398.2M
Beta
2.09
Average Volume
1.84M
Shares Outstanding (Diluted)
266.16M
Shares Change YoY
0.01%
Institutional Ownership
50.51%
Exchange
NASDAQ
ISIN
US05280R1005

Price Performance

Price Change 1M
-19.2%
Price Change 3M
16.9%
Price Change 6M
45.9%
Price Change YTD
3.7%
Price Change 1Y
40.6%
Price Change 3Y
-17.1%
Price Change 5Y
-69.2%
1M CAGR (ann.)
-3.0%
1Y CAGR (ann.)
52.8%
5Y CAGR (ann.)
-22.2%
All-Time CAGR
-26.6%

Valuation

PE Ratio
-1.83
Forward PE
N/A
PEG Ratio
0.07
Forward PEG
0.09
PS Ratio
4.40
Forward PS
2.60
PB Ratio
6.90
P/FCF Ratio
-2.17
P/Adj. FCF Ratio
-2.04
P/OCF Ratio
-2.28
EV/Sales
3.39
EV/EBIT
-1.71
EV/EBITDA
-1.80
EV/FCF
-1.68
Earnings Yield
-54.6%
FCF Yield
-46.0%
Adj. FCF Yield
-49.0%

Financial Health

Net Cash
$201.63M
Total Debt
$83.51M
Cash & Short-Term Investments
$201.63M
Total Assets
$493.23M
Current Ratio
4.89
Quick Ratio
4.40
Debt / Equity Ratio
1.12
Debt / EBITDA
-0.38
Debt / FCF
-0.35
OCF / Debt
-2.70
Interest Coverage
-5.25
Altman Z-Score
-4.18
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
15.7%
Operating Profit Margin
-210.8%
EBITDA Margin
-188.7%
Net Profit Margin
-238.6%
FCF Margin
-202.3%
Adj. FCF Margin
-215.5%
SBC / Revenue
13.2%
SBC Impact (per share)
-6.5%

Returns

Return on Assets
-56.8%
Return on Equity
-178.6%
Return on Invested Capital
-57.5%
Return on Capital Employed
-58.3%
Return on Tangible Assets
-59.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.3%
Revenue CAGR 5Y
108.2%
Revenue CAGR 10Y
95.2%
EPS CAGR 3Y
4.9%
EPS CAGR 5Y
16.5%
EPS CAGR 10Y
2.4%
FCF CAGR 3Y
-16.1%
FCF CAGR 5Y
-21.0%
FCF CAGR 10Y
-23.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
14
EPS Growth Next 3Y
29.6%
Revenue Growth Next 3Y
58.0%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$8.87
Price Target Upside
357.2%

Cash Flow

Operating Cash Flow
$-225.61M
Free Cash Flow
$-237.45M
Adj. Free Cash Flow
$-252.89M
FCF Per Share
-$0.89
OCF Per Share
-$0.85
OCF/S Ratio
-192.2%

Income Statement

Revenue
$117.35M
Gross Profit
$18.38M
Operating Income
$-247.33M
EBITDA
$-221.4M
Net Income
$-280.03M
EPS (Diluted)
-$1.06
Revenue / Employee
$156.06K
Profit / Employee
$-372.38K
Employees
752

© 2026 bestshares.com. All rights reserved.